PURA VIDA INVESTMENTS, LLC - Q3 2015 holdings

$175 Million is the total value of PURA VIDA INVESTMENTS, LLC's 66 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 52.9% .

 Value Shares↓ Weighting
CI SellCIGNA CORPORATION$8,236,000
-12.0%
61,000
-6.2%
4.70%
-1.9%
UHS BuyUNIVERSAL HLTH SVCS INCcl b$8,088,000
-7.2%
64,800
+8.0%
4.62%
+3.5%
TFX BuyTELEFLEX INC$7,142,000
+9.2%
57,500
+17.8%
4.08%
+21.8%
SYK BuySTRYKER CORP$7,058,000
+38.0%
75,000
+50.0%
4.03%
+53.9%
BSX BuyBOSTON SCIENTIFIC CORP$6,810,000
+67.1%
415,000
+76.6%
3.89%
+86.3%
TFX  TELEFLEX INCcall$6,211,000
-8.3%
50,0000.0%3.54%
+2.3%
PFE BuyPFIZER INC$6,121,000
+19.1%
194,875
+36.8%
3.49%
+32.8%
SNN NewSMITH & NEPHEW PLCcall$5,250,000150,000
+100.0%
3.00%
NXTM BuyNXSTAGE MEDICAL INC$4,889,000
+31.6%
310,000
+19.1%
2.79%
+46.7%
PODD BuyINSULET CORP$4,679,000
+38.1%
180,600
+80.6%
2.67%
+54.0%
JNJ NewJOHNSON & JOHNSONput$4,668,00050,000
+100.0%
2.66%
T107PS BuyWRIGHT MEDICAL GROUP INC$4,416,000
+42.3%
210,101
+74.9%
2.52%
+58.7%
VRX BuyVALEANT PHARMACEUTICALS INTL$4,125,000
+28.1%
23,125
+85.0%
2.35%
+42.9%
ABBV BuyABBVIE INC$4,026,000
+0.2%
74,000
+29.0%
2.30%
+11.8%
HOLX NewHOLOGIC INCcall$3,913,000100,000
+100.0%
2.23%
LLY BuyLILLY ELI & CO$3,703,000
+65.3%
44,250
+67.0%
2.11%
+84.4%
CYBX  CYBERONICS INC$3,647,000
-1.0%
60,0000.0%2.08%
+10.4%
ARAY BuyACCURAY INC$3,565,000
+47.1%
713,700
+87.8%
2.04%
+64.0%
NUVA SellNUVASIVE INC$3,509,000
-32.2%
72,780
-22.7%
2.00%
-24.4%
SPNC BuySPECTRANETICS CORPcall$3,419,000
+98.1%
290,000
+286.7%
1.95%
+121.0%
ABT NewABBOTT LABS$3,218,00080,000
+100.0%
1.84%
BMY BuyBRISTOL MYERS SQUIBB CO$3,182,000
-4.2%
53,750
+6.2%
1.82%
+6.8%
CYNA  CYNAPSUS THERAPEUTICS INC$3,102,000
-1.4%
194,4610.0%1.77%
+9.9%
VAR NewVARIAN MED SYS INC$2,951,00040,000
+100.0%
1.68%
VNDA SellVANDA PHARMACEUTICALS INC$2,792,000
-25.8%
247,500
-19.5%
1.59%
-17.3%
ALIM NewALIMERA SCIENCES INCcall$2,763,0001,250,000
+100.0%
1.58%
PRGO BuyPERRIGO CO PLC$2,752,000
-16.4%
17,500
+2.2%
1.57%
-6.7%
KITE BuyKITE PHARMA INC$2,714,000
+3.6%
48,750
+35.4%
1.55%
+15.5%
WMGIZ BuyWRIGHT MEDICAL GROUP RIGHTSright 03/01/2019$2,648,000
+21.9%
585,836
+0.1%
1.51%
+35.9%
BXLT NewBAXALTA INC$2,521,00080,000
+100.0%
1.44%
ELGX NewENDOLOGIX INC$2,515,000205,100
+100.0%
1.44%
EW SellEDWARDS LIFESCIENCES CORP$2,488,000
-34.6%
17,500
-30.0%
1.42%
-27.1%
JAZZ  JAZZ PHARMACEUTICALS PLC$2,391,000
-30.9%
18,0000.0%1.36%
-22.9%
AFFX SellAFFYMETRIX INC$2,391,000
-27.3%
280,000
-6.7%
1.36%
-18.9%
OMI SellOWENS & MINOR INC NEW$2,236,000
-39.4%
70,000
-33.3%
1.28%
-32.5%
QGEN SellQIAGEN NV$2,193,000
-21.6%
85,000
-15.0%
1.25%
-12.6%
SGYPQ BuySYNERGY PHARMACEUTICALS DEL$2,120,000
-5.6%
400,000
+62.4%
1.21%
+5.3%
ALXN  ALEXION PHARMACEUTICALS INC$1,955,000
-20.8%
12,5000.0%1.12%
-11.6%
SNN SellSMITH & NEPHEW PLCspdn adr new$1,925,000
-50.5%
55,000
-47.6%
1.10%
-44.7%
AGN NewALLERGAN PLC$1,903,0007,000
+100.0%
1.09%
BCR NewBARD C R INC$1,863,00010,000
+100.0%
1.06%
TRXC BuyTRANSENTERIX INC$1,832,000
-26.5%
810,404
+6.4%
1.05%
-18.0%
EWA NewISHARESput$1,792,000100,000
+100.0%
1.02%
ALQA BuyALLIQUA BIOMEDICAL INC$1,658,000
-20.7%
523,000
+24.5%
0.95%
-11.7%
ZLTQ NewZELTIQ AESTHETICS INC$1,602,00050,000
+100.0%
0.91%
AKRXQ BuyAKORN INC$1,431,000
-33.8%
50,200
+7.1%
0.82%
-26.1%
SAGE  SAGE THERAPEUTICS INC$1,185,000
-38.1%
28,0000.0%0.68%
-31.0%
TNXP BuyTONIX PHARMACEUTICALS HLDG C$1,100,000
-17.4%
207,900
+31.7%
0.63%
-7.8%
PEN NewPENUMBRA INC$1,035,00025,800
+100.0%
0.59%
FLKS NewFLEX PHARMA INC$865,00072,000
+100.0%
0.49%
ZGNX BuyZOGENIX INC$793,000
-18.9%
58,750
+16.0%
0.45%
-9.6%
BDSI NewBIODELIVERY SCIENCES INTL IN$751,000135,000
+100.0%
0.43%
FOMX NewFOAMIX PHAMACEUTICALS LTD$748,000102,000
+100.0%
0.43%
FEIC SellFEI CO$730,000
-43.4%
10,000
-33.3%
0.42%
-36.8%
DYAX BuyDYAX CORP$449,000
-19.0%
23,500
+4.4%
0.26%
-9.9%
OCRX BuyOCERA THERAPEUTICS INC$414,000
-10.0%
131,000
+11.6%
0.24%
+0.4%
PTCT  PTC THERAPEUTICS INCcall$401,000
-44.5%
15,0000.0%0.23%
-38.1%
CBAY  CYMABAY THERAPEUTICS INC$388,000
-35.5%
200,0000.0%0.22%
-28.2%
ALDX  ALDEYRA THERAPEUTICS INC$335,000
-34.4%
57,5000.0%0.19%
-27.1%
ADMP  ADAMIS PHARMACEUTICALS CORP$312,000
-7.4%
80,5000.0%0.18%
+3.5%
CPRX SellCATALYST PHARM PARTNES INC$300,000
-84.6%
100,129
-74.7%
0.17%
-82.9%
CBYL BuyCARBYLAN THERAPEUTICS INC$286,000
+3.6%
80,000
+100.0%
0.16%
+15.6%
ITEK NewINOTEK PHARMACEUTICALS CORP$252,00026,800
+100.0%
0.14%
EVAR  LOMBARD MED INC$189,000
-12.5%
52,8750.0%0.11%
-2.7%
SRPT  SAREPTA THERAPEUTICS INCcall$173,000
+5.5%
5,4000.0%0.10%
+17.9%
ALIM SellALIMERA SCIENCES INC$100,000
-98.3%
45,207
-96.4%
0.06%
-98.1%
STAA ExitSTAAR SURGICAL CO$0-17,204
-100.0%
-0.08%
ARAY ExitACCURAY INCcall$0-50,000
-100.0%
-0.16%
ExitNEURODERM LTD$0-53,000
-100.0%
-0.52%
IPXL ExitIMPAX LABORATORIES INC$0-21,543
-100.0%
-0.53%
IRWD ExitIRONWOOD PHARMACEUTICALS INC$0-100,000
-100.0%
-0.54%
NXTM ExitNXSTAGE MEDICAL INCcall$0-100,000
-100.0%
-0.73%
ESPR ExitESPERION THERAPEUTICS INC NEput$0-34,500
-100.0%
-1.10%
THOR ExitTHORATEC CORPput$0-50,000
-100.0%
-1.14%
AGN ExitALLERGAN INC$0-7,000
-100.0%
-1.19%
RCPT ExitRECEPTOS INC$0-11,000
-100.0%
-1.28%
FEIC ExitFEI COcall$0-30,000
-100.0%
-1.32%
PTCT ExitPTC THERAPEUTICS INCput$0-60,000
-100.0%
-1.48%
BIIB ExitBIOGEN INC$0-9,250
-100.0%
-1.51%
CPHD ExitCEPHEID$0-60,000
-100.0%
-1.71%
A ExitAGILENT TECHNOLOGIES INCcall$0-100,000
-100.0%
-1.97%
SPNC ExitSPECTRANETICS CORP$0-250,000
-100.0%
-2.19%
COO ExitCOOPER COS INC$0-25,000
-100.0%
-2.26%
TMO ExitTHERMO FISHER SCIENTIFIC INCcall$0-37,500
-100.0%
-2.49%
SIEN ExitSIENTRA INC$0-241,402
-100.0%
-2.87%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ICU MED INC26Q2 20234.2%
NANOSTRING TECHNOLOGIES INC26Q2 20233.3%
VIEWRAY INC25Q2 20233.2%
LIVANOVA PLC23Q3 20233.8%
ALEXION PHARMACEUTICALS INC23Q1 20214.3%
INSPIRE MED SYS INC22Q3 20233.7%
BOSTON SCIENTIFIC CORP22Q3 20224.8%
INVACARE CORP22Q3 20212.8%
ESTABLISHMENT LABS HLDGS INC21Q3 20235.0%
INTERSECT ENT INC21Q2 20212.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
PURA VIDA INVESTMENTS, LLC Q3 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Stryve Foods Holdings, LLCApril 19, 20231,470,6495.6%
ICAD INCMarch 15, 20231,277,2145.0%
ESTABLISHMENT LABS HOLDINGS INC.February 14, 20231,002,7674.1%
Pulmonx CorpFebruary 14, 20231,216,2583.2%
Quotient LtdSold outFebruary 14, 202300.0%
Universe Pharmaceuticals INCSold outFebruary 14, 202300.0%
MedMen Enterprises, Inc.April 29, 2022139,755,07221.4%
INVACARE CORPSold outFebruary 14, 202200.0%
MedAvail Holdings, Inc.February 14, 2022714,1202.2%
TELA Bio, Inc.February 14, 2022564,1203.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2024-02-13
SC 13D/A2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

Compare quarters

Export PURA VIDA INVESTMENTS, LLC's holdings